These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18445367)

  • 1. Effects of diabetes mellitus induced by alloxan on the pharmacokinetics of metformin in rats: restoration of pharmacokinetic parameters to the control state by insulin treatment.
    Lee MG; Choi YH; Lee I
    J Pharm Pharm Sci; 2008; 11(1):88-103. PubMed ID: 18445367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1.
    Lee DY; Lee MG; Shin HS; Lee I
    J Pharm Pharm Sci; 2007; 10(4):420-33. PubMed ID: 18261364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
    Bae SK; Kim JY; Yang SH; Kim JW; Kim T; Lee MG
    Life Sci; 2006 Apr; 78(20):2287-94. PubMed ID: 16288785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin.
    Kim YC; Oh EY; Kim SH; Lee MG
    Biopharm Drug Dispos; 2006 Mar; 27(2):85-92. PubMed ID: 16312011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin.
    Choi YH; Lee MG
    Br J Pharmacol; 2006 Oct; 149(4):424-30. PubMed ID: 16940989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telithromycin pharmacokinetics in rat model of diabetes mellitus induced by alloxan or streptozotocin.
    Lee JH; Lee MG
    Pharm Res; 2008 Aug; 25(8):1915-24. PubMed ID: 18478316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation.
    Kim YC; Lee AK; Lee JH; Lee I; Lee DC; Kim SH; Kim SG; Lee MG
    Eur J Pharm Sci; 2005 Sep; 26(1):114-23. PubMed ID: 15985363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in metformin pharmacokinetics after intravenous and oral administration to rats with short-term and long-term diabetes induced by streptozotocin.
    Choi YH; Lee DC; Lee I; Lee MG
    J Pharm Sci; 2008 Dec; 97(12):5363-75. PubMed ID: 18393297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bacterial lipopolysaccharide on the pharmacokinetics of metformin in rats.
    Choi YH; Lee I; Lee MG
    Int J Pharm; 2007 Jun; 337(1-2):194-201. PubMed ID: 17275228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin.
    Kim YC; Oh EY; Kim SH; Lee MG
    Biopharm Drug Dispos; 2005 Nov; 26(8):371-8. PubMed ID: 16094676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of water deprivation on the pharmacokinetics of metformin in rats.
    Choi YH; Lee I; Lee MG
    Biopharm Drug Dispos; 2007 Oct; 28(7):373-83. PubMed ID: 17657786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slower clearance of intravenous metformin in rats with acute renal failure induced by uranyl nitrate: contribution of slower renal and non-renal clearances.
    Choi YH; Lee I; Lee MG
    Eur J Pharm Sci; 2010 Jan; 39(1-3):1-7. PubMed ID: 19454315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for preclinical pharmacokinetic investigation in streptozotocin-induced diabetes mellitus (DMIS) and alloxan-induced diabetes mellitus (DMIA) rat models: case studies and perspectives.
    Srinivas NR
    Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):1-12. PubMed ID: 24596068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Musa sapientum L. on pharmacokinetic of metformin in diabetic gastroparesis.
    Darvhekar V; Tripathi AS; Jyotishi SG; Mazumder PM; Shelke PG
    Chin J Integr Med; 2016 Oct; 22(10):783-8. PubMed ID: 27460491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cysteine on metformin pharmacokinetics in rats with protein-calorie malnutrition: partial restoration of some parameters to control levels.
    Choi YH; Lee I; Lee MG
    J Pharm Pharmacol; 2008 Feb; 60(2):153-61. PubMed ID: 18237462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interaction between telithromycin and metformin in diabetes mellitus rats.
    Lee JH; Kang HE; Lee MG
    Xenobiotica; 2010 Mar; 40(3):217-24. PubMed ID: 20039777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
    Baek HW; Bae SK; Lee MG; Sohn YT
    J Pharm Sci; 2006 Nov; 95(11):2452-62. PubMed ID: 16886191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus.
    Lee JH; Yang SH; Oh JM; Lee MG
    J Pharm Pharmacol; 2010 Jan; 62(1):1-23. PubMed ID: 20722995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus.
    Kim YC; Lee JH; Kim SH; Lee MG
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2528-32. PubMed ID: 15917564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hepatic CYP2D1 activity and hepatic clearance in type I and type II diabetic rat models, before and after treatment with insulin and metformin.
    Neyshaburinezhad N; Seidabadi M; Rouini M; Lavasani H; Foroumadi A; Ardakani YH
    Daru; 2020 Dec; 28(2):479-487. PubMed ID: 32378154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.